Literature DB >> 4269702

Immunotherapy in patients with melanoma.

H F Seiger, W W Shingleton, R S Metzgar, C E Buckley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4269702      PMCID: PMC1355817          DOI: 10.1097/00000658-197309000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  25 in total

1.  Cellular and humoral immunity to different types of human neoplasms.

Authors:  I Hellström; K E Hellström; G E Pierce; J P Yang
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

2.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

Review 3.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

4.  Transplanted carcinoma in an immunosuppressed patient.

Authors:  B Matter; C F Zukoski; D A Killen; E Ginn
Journal:  Transplantation       Date:  1970-01       Impact factor: 4.939

Review 5.  Transplantation methods as a tool for detection of tumor-specific antigens.

Authors:  H O Sjögren
Journal:  Prog Exp Tumor Res       Date:  1965

6.  Immunological studies on a human tumor. Dilemmas of the experimentalist.

Authors:  G Klein
Journal:  Isr J Med Sci       Date:  1971-01

7.  Detection of tissue isoantigens on primary and serial heteroploid cell lines of human origin by the mixed agglutination technique.

Authors:  R S Metzgar; J F Flanagan; C M Zmijewski
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

8.  Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.

Authors:  M G Lewis; R L Ikonopisov; R C Nairn; T M Phillips; G H Fairley; D C Bodenham; P Alexander
Journal:  Br Med J       Date:  1969-09-06

9.  Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.

Authors:  B Zbar; T Tanaka
Journal:  Science       Date:  1971-04-16       Impact factor: 47.728

10.  Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus.

Authors:  F R Eilber; D L Morton
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

View more
  8 in total

1.  Melanoma of the head and neck.

Authors:  M N Harris; D F Roses; A T Culliford; S L Gumport
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

2.  Viral infection-homograft interactions in a murine model.

Authors:  J D Hamilton; J F Fitzwilliam; K S Cheung; J Shelburne; D J Lang; D B Amos
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

Review 3.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

4.  Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.

Authors:  E Yarkoni; L Peters; H J Rapp; M G Hanna; J T Hunter
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

5.  Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients.

Authors:  S Fujimoto; M Takahashi; T Minami; H Ishigami; M Miyazaki; K Itoh
Journal:  Jpn J Surg       Date:  1979-09

6.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

7.  An ultrastructural analysis of breast carcinoma presenting as isolated axillary adenopathy.

Authors:  J D Iglehart; B J Ferguson; W W Shingleton; D C Sabiston; J S Silva; B F Fetter; K S McCarty
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

8.  Cellular immunocompetence in melanoma: effect of extent of disease and immunotherapy.

Authors:  V K Lui; J Karpuchas; P B Dent; P B McCulloch; M A Blajchman
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.